Concepedia

In vitro and in vivo interaction between cisplatin and topotecan in ovarian carcinoma systems

Simona Romanelli, Paola Perego, Graziella Pratesi, Nives Carenini, Monica Tortoreto, Franco Zunino

Cancer Chemotherapy and Pharmacology · 1998 · 116 citations · 17 references

DOI

Concepts

References

17

Cellular pharmacology of cisplatin: perspectives on mechanisms of acquired resistance.

Andrews Pa, Howell Sb · PubMed · 1990 · 401 citations

, , +16

Association between cisplatin resistance and mutation of p53 gene and reduced bax expression in ovarian carcinoma cell systems.

Paola Perego, Monica Giarola, Sabina Carla Righetti et al. · PubMed · 1996 · 393 citations

, , +16

Phase I and pharmacologic study of topotecan: a novel topoisomerase I inhibitor.

Eric K. Rowinsky, L B Grochow, Carolyn B. Hendricks et al. · Journal of Clinical Oncology · 1992 · 358 citations

, , +15

Enhanced DNA repair as a mechanism of resistance to cis-diamminedichloroplatinum(II)

Alan Eastman, Nancy A. Schulte · Biochemistry · 1988 · 314 citations

, , +9

Characterization of a human ovarian adenocarcinoma line, IGROV1, in tissue culture and in nude mice.

Jean Bénard, J Da Silva, Mathilde Blois et al. · PubMed · 1985 · 293 citations

, , +14